Silicon Labs Q2 Revenue Jumps 18% to $228M, Loss Narrows; Guides Q3 Above Consensus

summarizeSummary

Silicon Labs reported Q2 revenue of $228.2M, up 18% YoY, with non-GAAP EPS of $0.71, a 545% increase. Q3 guidance of $235M-$245M topped consensus, and the operating loss narrowed sharply.

check_boxKey Events · Earnings and Guidance · SLAB

• Q2 Revenue Beats, Up 18% YoY

  Revenue reached $228.2 million, driven by a 78% surge in Medical and 23% growth in Industrial & Commercial. Non-GAAP EPS of $0.71 was a 545% increase year-over-year.

• Q3 Guidance Tops Consensus

  The company guided Q3 revenue to $235–$245 million, above the $230 million consensus, signaling continued momentum.

• Operating Loss Narrows Sharply

  Operating loss improved to $10.7 million from $22.9 million a year ago, as gross margin expanded to 61.6% from 56.1%.

• Merger Costs Accumulate

  Merger-related costs with Texas Instruments totaled $9.6 million in Q2 and $20.8 million in H1 2026, with the deal expected to close in the first half of 2027.

auto_awesomeAnalysis · SLAB · Manufacturing

Silicon Labs delivered a strong Q2 with revenue up 18% year-over-year to $228.2 million, driven by a 78% surge in Medical and a 23% increase in Industrial & Commercial. Non-GAAP EPS of $0.71 marked a 545% improvement, and the company guided Q3 revenue to $235–$245 million, above the $230 million consensus. The operating loss narrowed significantly to $10.7 million from $22.9 million a year ago, while merger-related costs with Texas Instruments totaled $20.8 million in the first half. With $397.2 million in cash and no debt, the balance sheet remains solid, though inventory rose to $123.3 million. The results reinforce the recovery narrative ahead of the expected merger close in the first half of 2027.